Tiffany Y Sia, Vivian Wan, Michael Finlan, Qin C Zhou, Alexia Iasonos, Oliver Zivanovic, Yukio Sonoda, Dennis S Chi, Kara Long Roche, Elizabeth Jewell, William P Tew, Roisin E O'Cearbhaill, Seth Cohen, Vicky Makker, Ying L Liu, Claire F Friedman, Chrisann Kyi, Dmitriy Zamarin, Ginger Gardner
OBJECTIVE: To evaluate the feasibility and outcomes of performing procedural interventions, defined as surgical resection, tumor ablation, or targeted radiation therapy, for oligoprogressive disease among patients with gynecologic malignancies who are treated with immune checkpoint blockade. METHODS: Patients with gynecologic cancers treated with immune checkpoint blockade between January 2013 and October 2021 who underwent procedural interventions including surgical resection, interventional radiology ablation, or radiation therapy for oligoprogressive disease were identified...
January 31, 2024: International Journal of Gynecological Cancer